ALMIRALL, S.A. 25/06/2019 07:14 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks. - Announcements of public presentations and meetings Conference call with analysts and institutional investors: Presentation of License Agreement of lebrikizumab for Atopic Dermatitis in Europe Número de registro: 279523